Effect of recombinant human granulocyte colony stimulating factor (lenograstim) on chemotherapy induced nuetropenia in patients with urothelial cancer

International Journal of Urology

Volumn 6, Issue 2, 1999, Pages 61-67

  Kotake, Toshihiko ^a   Usami, Michiyuki ^a   Miki, Tsuneharu ^b   Togashi, Masaki ^c   Akaza, Hideyuki ^d   Kubota, Yoshinobu ^e   Matsumura, Yousuke ^f  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f KOBE CITY MEDICAL CENTER WEST HOSPITAL   (Japan)

Author keywords

Granulocyte colony stimulating factor; Neutropenia; Urothelial cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLINESTERASE; CISPLATIN; DOXORUBICIN; LACTATE DEHYDROGENASE; METHOTREXATE; NITROGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UREA; VINBLASTINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; INFECTION; LABORATORY TEST; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; NECK PAIN; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; URINARY TRACT CANCER; UROTHELIUM;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; CISPLATIN; DOXORUBICIN; FEMALE; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INCIDENCE; LEUKOCYTE COUNT; MALE; METHOTREXATE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; RECOMBINANT PROTEINS; STOMATITIS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS; UROTHELIUM; VINBLASTINE;

EID: 0033512939     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.1999.00624.x     Document Type: Article

References (16)

1. 1 Kotake T. Chemotherapy of invasive bladder cancer. Jpn. J. Cancer Chemother. 1991; 18: 2375-82.
2. 2 Matsumura Y, Tsushima T. chemotherapy for urogenital cancers. Jpn. J. Urol. 1991; 82: 181-9.
3. 3 Yagoda A. The role of cisplatin-based chemotherapy in advanced urothelial tract cancer. Semin. Oncol. 1989; 16: 98-104.
4. 4 Sternberg CN, Yagoda A, Scher HI et al. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol. 1988; 139: 461-9.
5. 5 Kotake T, Akaza H, Isaka S et al. Evaluation of systemic chemotherapy with methotrexate, vinblastine, adriamycin and cisplatin for advanced bladder cancer. Cancer Chemother. Pharmacol. 1992; 30 (Suppl.): S85-9.
6. 6 Gabrilove JL, Jakubowski A, Sher H et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N. Engl. J. Med. 1988; 318: 1414-22.
7. 7 Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N. Engl. J. Med. 1991; 325: 164-70.
8. 8 Oheda M, Hase S, Ono M, Ikenaka T. Structures of the sugar chains of recombinant human granulocyte colony-stimulating factor produced by Chinese hamster ovary cells. J. Biochem. 1988; 103: 544-6.
9. 9 Kubota N, Orita T, Hattori K, Oh-eda M, Ochi N, Yamazaki T. Structural characterization of natural and recombinant human granulocyte colony-stimulating factors. J. Biochem. 1990; 107: 486-92.
10. 10 Kamachi S, Motojima H, Oheda M et al. Characteristics of natural human granulocyte colony-stimulating factor (G-CSF). Clin. Rep. 1991; 25: 4061-6.
11. 11 Oyama A, Ota K, Asano S et al. A double-blind, cross-over clinical trial of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma. J. Jpn. Soc. Cancer Ther. 1990; 25: 2533-48.
12. 12 Ota K, Ariyoshi Y, Fukuoka M, Furuse K, Niitani H. Clinical effect of recombinant human G-CSF on neutropenia induced by the chemotherapy for lung cancer. Jpn. J. Cancer Chemother. 1990; 17: 65-71.
13. 13 Terashima Y, Ochiai K, Hashimoto M et al. A clinical study of recombinant human G-CSF in gynecological tumor patients with neutropenia due to chemotherapy. J. Jpn. Soc. Cancer Ther. 1990; 25: 1461-71.
14. 14 Kotake T, Miki T, Aso Y et al. Clinical effect of human granulocyte colony-stimulating factor on neutropenia due to chemotherapy for urogenital cancer. J. Urol. Surg. 1990; 3: 1017-27.
15. 15 Kotake T, Miki T, Akaza H et al. Effect of recombinant granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with urogenital cancer. Cancer Chemother. Pharmacol. 1991; 27: 253-7.
16. 16 Aso Y Akaza H, Kumamoto Y et al. Phase III study of KRN8601 (rhG-CSF) on neutropenia induced by chemotherapy for transitional cell carcinoma of urinary tract. J. Urol. Surg. 1994; 7: 189-99.